Navigation Links
The Leukemia & Lymphoma Society Awards $12 Million in Research Grants in Four Critical Areas of Unmet Medical Need
Date:8/23/2012

prevention of anthracycline-related cardiomyopathy 
  • Ruben Niesvizky, M.D., Joan & Sanford I. Weill Medical College of Cornell University, Stem cell alterations in lenalidomide treated myeloma patients 
  • Pavan Reddy, M.D., University of Michigan, Alpha 1-antitypsin as a novel strategy to modulate GVHD 
  • Daniela Salvemini, Ph.D, Saint Louis University, Blocking bortezomib induced painful peripheral neuropathy with FTY720 
  • LLS also announced the awarding of an additional 28 TRP grants, totaling $15.6 million, to scientists working in other areas of blood cancer research.

    "By issuing RFP's LLS is taking a strategic approach to identifying and prioritizing areas of need and directing funding to research that shows the most promise for improving survival and quality of life for patients with these particularly difficult diseases," said Richard Winneker, Ph.D., LLS's SVP, Research.

    About The Leukemia & Lymphoma Society
    The Leukemia & Lymphoma Society ® (LLS) is the world's largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin's disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services.

    Founded in 1949 and headquartered in White Plains, NY, LLS has chapters throughout the United States and Canada. To learn more, visit www.LLS.org or contact the Information Resource Center at (800) 955-4572, Monday through Friday, 9 a.m. to 6 p.m. ET. www.lls.org.

    Contact:  Andrea Greif
                  (914) 821-8958 
             
    '/>"/>

    SOURCE The Leukemia & Lymphoma Society
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related biology technology :

    1. MarketsandMarkets: Leukemia Therapeutics Market Worth $11.3 Billion by 2020
    2. TetraLogic Pharmaceuticals Announces Initiation of a Phase 1/2 Clinical Trial of TL32711 in Patients with Acute Myelogenous Leukemia (AML)
    3. MarketsandMarkets: Acute Lymphocytic Leukemia Therapeutics Market worth $3.88 Billion by 2020
    4. MarketsandMarkets: Chronic Lymphocytic Leukemia Therapeutics Market Worth $2.2 Billion by 2020
    5. MarketsandMarkets: Acute Myeloid Leukemia Therapeutics Market in G8 Countries Worth $1.67 Billion by 2020
    6. Cord Blood America Announces Exclusive Agreement With National Childrens Leukemia Foundation to Store Stem Cells
    7. TrovaGene, Inc. Obtains Exclusive License to Novel Mutations Associated with Prognosis and Chemotherapy Response in Leukemia
    8. Roche Launches 454 Sequencing Assays for High Sensitivity Genetic Variant Detection in Leukemia Samples to Drive Blood Cancer Research Worldwide
    9. Founder of National Childrens Leukemia Unveiled Non-Embryonic Stem Cell Treatment Promising Cure for Cancer at GIL 2012: Europe
    10. How Malignant Cells in Patients With Chronic Lymphocytic Leukemia Escape T Cell Recognition and Attack
    11. Acute Lymphocytic Leukemia: Impressive Results With the Monoclonal Antibody Blinatumomab in Patients With Refractory Disease
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/25/2014)... This research report “Biodegradable Plastics Market by ... Cellulose, PCL), by Application (Packaging, Fibers, Agriculture, Injection ... defines and segments the global biodegradable plastics market ... volume and value. , Browse 75 Market Data ... and in-depth TOC on “Biodegradable Plastics Market by ...
    (Date:10/25/2014)... Great Barrington, MA (PRWEB) October 25, 2014 ... contamination control products, is pleased to announce the ... to achieve the highest level of contamination containment ... in ISO Class 3 and higher cleanroom environments, ... continuous filament polyester knit laundered wiper that continues ...
    (Date:10/25/2014)... Investor-Edge has initiated coverage on ... ), Vertex Pharmaceuticals Inc. (NASDAQ: VRTX ), ... Pharmaceuticals Inc. (NASDAQ: PPHM ), and StemCells ... can be accessed at: http://investor-edge.com/register . ... on a positive note as the Dow Jones Industrial ...
    (Date:10/22/2014)... , Oct. 22, 2014 Research ... the "Global DNA Diagnostics Market (Product types, ... Share, Global Trends, Company Profiles, Demand, Insights, Analysis, ... 2020" report to their offering. ... (products, applications, techniques, end users and Geography) Global ...
    Breaking Biology Technology:Biodegradable Plastics Market Projected to $3,476.87 Million by 2019 - Report by MarketsandMarkets 2Biodegradable Plastics Market Projected to $3,476.87 Million by 2019 - Report by MarketsandMarkets 3Biodegradable Plastics Market Projected to $3,476.87 Million by 2019 - Report by MarketsandMarkets 4Ions Are Bygones, Berkshire Announces the Release of New Innovative Cleanroom Wipers 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020 2Global DNA Diagnostics Market (Product types, Application, Technology, End User and Geography) - Forecast to 2020 3
    ... Conn. , April 28 Goodwin Biotechnology Inc., a full ... development services company, jointly announced today their collaborative agreement to create ... services. , , , ... collaboration will enhance and strengthen the clinical development services integrating cDNA ...
    ... 28 The global biotechnology industry was able to ... financial performance in 2009, with the world,s established biotech centers ... gap between the "haves" and "have nots" in the industry ... companies in accessing the capital needed for R&D. These and ...
    ... ... of its Global Food, Agribusiness and Biofuels practice, presents findings today from a new ... and Agricultural Infrastructure" at the Land Conference 2010 organized by The World Bank in ... ...
    Cached Biology Technology:Goodwin Biotechnology Inc. and Hyprocell LLC Announce Collaboration 2Goodwin Biotechnology Inc. and Hyprocell LLC Announce Collaboration 3Biotech Industry Showing Resilience Despite Challenging Conditions 2Biotech Industry Showing Resilience Despite Challenging Conditions 3Biotech Industry Showing Resilience Despite Challenging Conditions 4Biotech Industry Showing Resilience Despite Challenging Conditions 5Biotech Industry Showing Resilience Despite Challenging Conditions 6Biotech Industry Showing Resilience Despite Challenging Conditions 7Private Sector Investment in Agriculture Emerging as a Significant Alternative Asset Class: New HighQuest Partners Study 2Private Sector Investment in Agriculture Emerging as a Significant Alternative Asset Class: New HighQuest Partners Study 3Private Sector Investment in Agriculture Emerging as a Significant Alternative Asset Class: New HighQuest Partners Study 4
    (Date:10/25/2014)... A recent report, "Genetic Testing Market Outlook 2018", provides ... testing market. A comprehensive introduction of gene-based tests, their ... On account of our analysis of the past and ... forecast for genetic testing has been drawn, according to ... CAGR of around 9% during 2013-2018. Our report ...
    (Date:10/22/2014)... (NASDAQ: AWRE ), a leading supplier of biometrics ... quarter ended September 30, 2014. Revenue for the ... 40% compared to $4.3 million in the same quarter last ... $4.1 million compared to $1.0 million in the third quarter ... period was primarily due to: i) a $1.0 million increase ...
    (Date:10/17/2014)... is critical and pertinent for practicing physicians and clinicians ... epidemic. The Journal, Disaster Medicine and Public Health ... and Public Health, to surround the public, medical professionals ... moment. , On October 17, the journal published ... primer was prepared by Dr. Eric Toner, internist and ...
    Breaking Biology News(10 mins):Genetic Testing Market Outlook 2018 2Aware, Inc. Reports Third Quarter 2014 Financial Results 2Aware, Inc. Reports Third Quarter 2014 Financial Results 3Aware, Inc. Reports Third Quarter 2014 Financial Results 4Aware, Inc. Reports Third Quarter 2014 Financial Results 5Aware, Inc. Reports Third Quarter 2014 Financial Results 6Aware, Inc. Reports Third Quarter 2014 Financial Results 7
    ... Groundbreaking research led by the U.S. Department of Energy ... time that the signatures of the genes alone in ... of the sampled environments. This study, published in the ... genome sequencing to accelerate advances in environmental sciences akin ...
    ... throughput microarray analyses result in many differentially expressed ... process of interest. In order to identify biological ... in which pairs of gene names and combinations ... , MEDLINE search strings for 15,621 known genes ...
    ... Joslin Diabetes Center have found genetic regions that, when defective, ... in a series of mis-steps that lead to type 1 ... journal Immunity, the researchers are now trying to hone in ... patients. , “The significance of this study is that we ...
    Cached Biology News:Study reveals new technique for fingerprinting environmental samples 2Study reveals new technique for fingerprinting environmental samples 3Genetic defects give the immune system the green light to attack the pancreas 2Genetic defects give the immune system the green light to attack the pancreas 3
    Rabbit polyclonal to Dishevelled 2 ( Abpromise for all tested applications). entrezGeneID: 1856 SwissProtID: O14641...
    ... Mouse anti-Cytohesin 2, Monoclonal Antibody, Unconjugated ... assay dependent dilution. ICC: Use at an assay ... 5 - 10 ug/ml, this concentration is determined ... molecular weight: 40 kDa. Not tested in other ...
    SHP-2 Antibody...
    ... Glycine Transporter 2, Neuronal (GLYT2). The ... from the central nervous system. The staining ... pattern described using in situ hybridization with ... has been described for glycinergic neurons. Preabsorption ...
    Biology Products: